Infertility Drugs 2018 Global Market Expected to Grow at CAGR 4.67 % and Forecast to 2022

Wise.Guy12

Wise.Guy.

WiseGuyReports.com adds “Global Infertility Drugs Market 2018-2022” reports to its Database.

PUNE, INDIA, February 9, 2018 /EINPresswire.com/ —

About Infertility Drugs

Infertility can be defined as an inability of a person to reproduce through natural means. Infertility can occur in any of the two genders, i.e., male and female.

Technavio’s analysts forecast the global infertility drugs market to grow at a CAGR of 4.67% during the period 2018-2022.

Covered in this report 
The report covers the present scenario and the growth prospects of the global infertility drugs market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography: 
• Americas 
• APAC 
• EMEA

Technavio's report, Global Infertility Drugs Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
• Bayer 
• Ferring 
• Merck 
• Novartis

 

 Request For Sample Report @ https://www.wiseguyreports.com/sample-request/2963418-global-infertility-drugs-market-2018-2022                       

Market driver 
• Growing lifestyle diseases 
• For a full, detailed list, view our report

Market challenge 
• Rising inclination toward other modes of treatment for infertility 
• For a full, detailed list, view our report

Market trend 
• Raising awareness regarding infertility in couples 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2022 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Table Of Contents:                                                                                                                          

PART 01: EXECUTIVE SUMMARY 
PART 02: SCOPE OF THE REPORT 
PART 03: RESEARCH METHODOLOGY 
PART 04: INTRODUCTION 
• Introduction 
• Diagnosis and treatment 
PART 05: MARKET LANDSCAPE 
• Market ecosystem 
• Market characteristics 
• Market segmentation analysis 
PART 06: MARKET SIZING 
• Market definition 
• Market sizing 
• Market size and forecast 
PART 07: FIVE FORCES ANALYSIS 
• Bargaining power of buyers 
• Bargaining power of suppliers 
• Threat of new entrants 
• Threat of substitutes 
• Threat of rivalry 
• Market condition 
PART 08: PIPELINE ANALYSIS 
PART 09: MARKET SEGMENTATION BY THERAPY 
• Segmentation by therapy 
• Comparison by therapy 
• Global hormone-based therapy market 
• Global others market 
• Market opportunity by therapy 
PART 10: MARKET SEGMENTATION BY GENDER 
• Segmentation by gender 
• Global female infertility drugs market 
• Global male infertility drugs market 
PART 11: CUSTOMER LANDSCAPE 
PART 12: REGIONAL LANDSCAPE 
• Geographical segmentation 
• Regional comparison 
• Infertility drugs market in Americas 
• Infertility drugs market in EMEA 
• Infertility drugs market in APAC 
• Market opportunity 
PART 13: DECISION FRAMEWORK 
PART 14: DRIVERS AND CHALLENGES 
• Market drivers 
• Market challenges 
PART 15: MARKET TRENDS 
• Raising awareness regarding infertility in couples 
• Growing online retail sales of drugs 
PART 16: VENDOR LANDSCAPE 
• Overview 
• Landscape disruption 
PART 17: VENDOR ANALYSIS 
• Vendors covered 
• Vendor classification 
• Market positioning of vendors 
• Bayer 
• Ferring 
• Merck 
• Novartis 

 Continued…….

Complete Report Details @ https://www.wiseguyreports.com/reports/2963418-global-infertility-drugs-market-2018-2022                             

 

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Hearing Implants 2018 Global Market Expected to Grow at CAGR 9.73 % and Forecast to 2022

Wise.Guy12

Wise.Guy.

WiseGuyReports.com adds “Global Hearing Implants Market 2018-2022” reports to its Database.

PUNE, INDIA, February 9, 2018 /EINPresswire.com/ —

About Hearing Implants 
Hearing implants are used when the normal function of the inner ear is damaged. These devices send sound signals artificially to the brain of the patients with severe hearing impairment to help them hear.

Technavio’s analysts forecast the global hearing implants market to grow at a CAGR of 9.73% during the period 2018-2022.

Covered in this report 
The report covers the present scenario and the growth prospects of the global hearing implants market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of hearing implants.

The market is divided into the following segments based on geography: 
• Americas 
• APAC 
• EMEA

Technavio's report, Global Hearing Implants Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
• Cochlear 
• MED-EL 
• Sonova 
• William Demant

 

 Request For Sample Report @ https://www.wiseguyreports.com/sample-request/2963443-global-hearing-implants-market-2018-2022                     

Market driver 
• Increasing prevalence of hearing loss 
• For a full, detailed list, view our report

Market challenge 
• High cost of hearing implants 
• For a full, detailed list, view our report

Market trend 
• Increasing focus on emerging markets 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2022 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Table Of Contents:                                                                                                                          

PART 01: EXECUTIVE SUMMARY 
PART 02: SCOPE OF THE REPORT 
PART 03: RESEARCH METHODOLOGY 
PART 04: MARKET LANDSCAPE 
• Market ecosystem 
• Market characteristics 
• Market segmentation analysis 
PART 05: MARKET SIZING 
• Market definition 
• Market sizing 2017 
• Market size and forecast 2017-2022 
PART 06: FIVE FORCES ANALYSIS 
• Bargaining power of buyers 
• Bargaining power of suppliers 
• Threat of new entrants 
• Threat of substitutes 
• Threat of rivalry 
• Market condition 
PART 07: MARKET SEGMENTATION BY PRODUCT TYPE 
• Overview 
• Comparison by product type 
• Global cochlear implants market 
• Global BAHA market 
• Global other hearing implants market 
• Market opportunity by product type 
PART 08: CUSTOMER LANDSCAPE 
PART 09: REGIONAL LANDSCAPE 
• Overview 
• Regional comparison 
• Hearing implants market in Americas 
• Hearing implants market in EMEA 
• Hearing implants market in APAC 
• Key leading countries 
• Market opportunity 
PART 10: DECISION FRAMEWORK 
PART 11: DRIVERS AND CHALLENGES 
• Market drivers 
• Market challenges 
PART 12: MARKET TRENDS 
• Emerging technological innovations 
• Increasing focus on emerging markets 
PART 13: VENDOR LANDSCAPE 
• Overview 
• Landscape disruption 
• Vendor landscape 
PART 14: VENDOR ANALYSIS 
• Vendors covered 
• Vendor classification 
• Market positioning of vendors 
• Cochlear 
• MED-EL 
• Sonova 
• William Demant 
• Other prominent vendors 

 Continued…….

Complete Report Details @ https://www.wiseguyreports.com/reports/2963443-global-hearing-implants-market-2018-2022                           

 

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

 

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Baobab Powder 2018 Global Market Expected to Grow at CAGR of 6.47% and Forecast to 2022

Wiseguyreports.Com Publish Market Research Report On -“Baobab Powder Market – Global Industry Analysis, Size, Share, Trends, Growth and Forecast 2018 – 2023”

PUNE, INDIA, February 9, 2018 /EINPresswire.com/ —

Baobab Powder Market 2018

Baobab powder is made from a super fruit called Baobab, which is also a rich source of vitamin C, calcium, and magnesium. It is consumed to boost health and vitality. The powder can be used as a health supplement and as a food ingredient. A natural source of dietary fibers, minerals and organic acids, Baobab powder also has antioxidant and prebiotic properties.

The analysts forecast the global baobab powder market to grow at a CAGR of 6.47% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global baobab powder market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of baobab powder.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2963408-global-baobab-powder-market-2018-2022

The report, Global Baobab Powder Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Halka B Organics
• Baobab Fruit Company Senegal
• Organic Africa
• ADUNA
• Atacora Essential
• Woodland Foods

Market driver
• Health benefits of baobab powder
• For a full, detailed list, view our report

Market challenge
• Growing popularity of substitutes
• For a full, detailed list, view our report

Market trend
• Growing popularity of baobab supplements
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

Complete Report Details @ https://www.wiseguyreports.com/reports/2963408-global-baobab-powder-market-2018-2022

Table of Contents –Analysis of Key Points

PART 01:EXECUTIVE SUMMARY
PART 02:SCOPE OF THE REPORT
PART 03:RESEARCH METHODOLOGY
• Market outline

PART 04:MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05:MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06:FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07:MARKET SEGMENTATION BY APPLICATION
• Segmentation by application
• Comparison by application
• Food – Market size and forecast 2017-2022
• Beverages – Market size and forecast 2017-2022
• Personal care – Market size and forecast 2017-2022
• Market opportunity by application

PART 08:CUSTOMER LANDSCAPE
PART 09:REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• EMEA – Market size and forecast 2017-2022
• Americas – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Key leading countries
• US
• Germany
• The UK
• France
• Market opportunity

PART 10:DECISION FRAMEWORK
PART 11:DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12:MARKET TRENDS
• Growing popularity of baobab supplements
• Increasing online purchasing trends
• Clean labeling

PART 13:VENDOR LANDSCAPE
• Overview
• Landscape disruption

PART 14:VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Halka B Organics
• Baobab Fruit Company Senegal
• Organic Africa
• ADUNA
• Atacora Essential
• Woodland Foods
..…..Continued

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Operational Technology Market 2018 – Industry Trends, Opportunities and Forecasts to 2025

This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

PUNE, INDIA, February 9, 2018 /EINPresswire.com/ — In this report, the global Operational Technology market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Operational Technology in these regions, from 2013 to 2025 (forecast), covering
United States
EU
China
Japan
South Korea
Taiwan

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2867379-global-operational-technology-market-research-report-2018

Global Operational Technology market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
SAP SE
IBM Limited
Cisco Systems
Oracle
Huawei Technologies
Hewlett-Packard Enterprise
NEC Corporation
Cognizant
Accenture
Wipro

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Wired Technology
Wireless Technology

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Process Industry
Non-Process Industry

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Operational Technology Market Research Report 2018
1 Operational Technology Market Overview
1.1 Product Overview and Scope of Operational Technology
1.2 Operational Technology Segment by Type (Product Category)
1.2.1 Global Operational Technology Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Operational Technology Production Market Share by Type (Product Category) in 2017
1.2.3 Wired Technology
1.2.4 Wireless Technology
1.3 Global Operational Technology Segment by Application
1.3.1 Operational Technology Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Process Industry
1.3.3 Non-Process Industry
1.4 Global Operational Technology Market by Region (2013-2025)
1.4.1 Global Operational Technology Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 United States Status and Prospect (2013-2025)
1.4.3 EU Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 South Korea Status and Prospect (2013-2025)
1.4.7 Taiwan Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Operational Technology (2013-2025)
1.5.1 Global Operational Technology Revenue Status and Outlook (2013-2025)
1.5.2 Global Operational Technology Capacity, Production Status and Outlook (2013-2025)

2 Global Operational Technology Market Competition by Manufacturers
2.1 Global Operational Technology Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Operational Technology Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Operational Technology Production and Share by Manufacturers (2013-2018)
2.2 Global Operational Technology Revenue and Share by Manufacturers (2013-2018)
2.3 Global Operational Technology Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Operational Technology Manufacturing Base Distribution, Sales Area and Product Type
2.5 Operational Technology Market Competitive Situation and Trends
2.5.1 Operational Technology Market Concentration Rate
2.5.2 Operational Technology Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Operational Technology Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Operational Technology Capacity and Market Share by Region (2013-2018)
3.2 Global Operational Technology Production and Market Share by Region (2013-2018)
3.3 Global Operational Technology Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Operational Technology Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 United States Operational Technology Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 EU Operational Technology Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Operational Technology Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Operational Technology Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 South Korea Operational Technology Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 Taiwan Operational Technology Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Operational Technology Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Operational Technology Consumption by Region (2013-2018)
4.2 United States Operational Technology Production, Consumption, Export, Import (2013-2018)
4.3 EU Operational Technology Production, Consumption, Export, Import (2013-2018)
4.4 China Operational Technology Production, Consumption, Export, Import (2013-2018)
4.5 Japan Operational Technology Production, Consumption, Export, Import (2013-2018)
4.6 South Korea Operational Technology Production, Consumption, Export, Import (2013-2018)
4.7 Taiwan Operational Technology Production, Consumption, Export, Import (2013-2018)

5 Global Operational Technology Production, Revenue (Value), Price Trend by Type
5.1 Global Operational Technology Production and Market Share by Type (2013-2018)
5.2 Global Operational Technology Revenue and Market Share by Type (2013-2018)
5.3 Global Operational Technology Price by Type (2013-2018)
5.4 Global Operational Technology Production Growth by Type (2013-2018)

6 Global Operational Technology Market Analysis by Application
6.1 Global Operational Technology Consumption and Market Share by Application (2013-2018)
6.2 Global Operational Technology Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

……Continued

Make an enquiry of this Report @ https://www.wiseguyreports.com/enquiry/2867379-global-operational-technology-market-research-report-2018

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Eye Care Surgical Devices 2018 Global Market Expected to Grow at CAGR of 7.57% and Forecast to 2022

Wiseguyreports.Com Publish Market Research Report On -“Eye Care Surgical Devices Market – Global Analysis, Size, Share, Trends, Growth and Forecast 2018 – 2023”

PUNE, INDIA, February 9, 2018 /EINPresswire.com/ —

Eye Care Surgical Devices Market 2018

Eye care surgical devices are used to treat eye disorders such as cataract, glaucoma, diabetic retinopathy, diabetic macular edema, and other eye-related surgical disorders.

The analysts forecast the global eye care surgical devices market to grow at a CAGR of 7.57% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global eye care surgical devices market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2924226-global-eye-care-surgical-devices-market-2018-2022

The report, Global Eye Care Surgical Devices Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Carl Zeiss Meditec
• Johnson & Johnson
• Novartis
• TOPCON
• Valeant Pharmaceuticals

Market driver
• High incidence of eye diseases
• For a full, detailed list, view our report

Market challenge
• Potential risk of complications with laser procedures
• For a full, detailed list, view our report

Market trend
• Availability of advanced technology
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

Complete Report Details @ https://www.wiseguyreports.com/reports/2924226-global-eye-care-surgical-devices-market-2018-2022

Table of Contents –Analysis of Key Points

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY APPLICATION
• Segmentation by application
• Comparison by application
• Cataract Surgery – Market size and forecast 2017-2022
• Glaucoma surgery – Market size and forecast 2017-2022
• Diabetic eye surgery – Market size and forecast 2017-2022
• Others – Market size and forecast 2017-2022
• Market opportunity by application

PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity

PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12: MARKET TRENDS
• Availability of advanced technology
• Shift toward ASCs for eye care
• Availability of advanced IOLs implants

PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario

PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Carl Zeiss Meditec
• Novartis
• Valeant Pharmaceuticals
• TOPCON
• Johnson & Johnson
..…..Continued

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

McKay-Dee Hospital Orthopedic Surgeon, Physical Therapist Provide Medical Support at 2018 Winter Olympics

SALT LAKE CITY, UTAH, USA, February 8, 2018 /EINPresswire.com/ — Dr. Jeff Harrison, an orthopedic surgeon and Sports Medicine Director at Intermountain McKay-Dee Orthopedics and Sports Medicine, is the Head Team Physician for the U.S. Women’s Alpine Ski Team and will be representing the United States as medical staff during the 2018 Winter Olympics in Pyeongchang, South Korea.

Doug Flint, a physical therapist at Intermountain McKay-Dee Sports Medicine, is also traveling to South Korea to provide medical support for Sweden and Norway’s moguls teams during the Winter Games.

As the Head Team Physician, Dr. Harrison will help ensure Olympic Medal hopefuls like Lindsey Vonn and Mikaela Shiffrin stay healthy throughout the Winter Olympics. He will oversee all medical care for the ten women on the U.S. Alpine Ski Team. He will also evaluate and treat injuries on the hill if the need arises, but hopes that the athletes complete all their runs safely.

Dr. Harrison has been a member of the U.S. Ski and Snowboard Association physician pool since 1998, and he is an expert orthopedic surgeon specializing in knee and shoulder surgery at home. Dr. Harrison has provided medical care to world-class athletes on and off the slopes for years. He has lent his medical expertise to five world championships and served as the Venue Medical Officer at Snowbasin Resort during the 2002 Winter Olympics in Utah.

“I’m looking forward to going to South Korea,” Dr. Harrison said. “I’ve never been to Asia, so that’s going to be exciting. Ski races are all somewhat similar, but I think the cultural exchange is what I’m looking forward to most.”

“It will also be exciting because the U.S. is going to have a really good team this year with Mikaela and Lindsey,” Harrison continued. “I think we’re going to win some medals.”

In addition to Shiffrin and Vonn, Dr. Harrison also said to keep an eye out for Breezy Johnson and Stacey Cook, who each have a good shot at medaling this year.

Doug Flint, a physical therapist at Intermountain Sports Medicine McKay-Dee Hospital, is also traveling to South Korea for the Winter Olympics. He is team physiotherapist for Sweden and Norway’s moguls teams and keeps those athletes healthy and conditioned to compete for their nations.

Flint is responsible for assessing and managing injuries, but devotes a great deal of his effort to preventing those injuries through proper warm ups, custom workouts, and proper exercise recovery.

“On competition days, I take care of last-minute physical issues, check equipment, and fit them into their skis properly,” said Flint. “I also assist the head coach at the starting line with any other issues that come up.”

Flint has worked as a physical therapist with many teams throughout his career. He has worked with the U.S., Sweden, Norway, and many other countries throughout 40 World Cup events, four World Championships, and now two Olympic Games.

During the 2018 Olympics, Flint recommends keeping an eye out for Hedvig Wessel and Vinjar Slatten from Norway and Ludwig Fjalstrom from Sweden, who has recovered from a surgical A.C.L. repair well in just ten months.

Though Flint and Dr. Harrison are providing medical expertise at the Olympic Games, they work very closely with local athletes of all abilities. When asked about everyday skiers staying safe on the slopes, Dr. Harrison said:

“Fitness level is very important. Also, there are ways to fall that are better than others. If you fall forward instead of backward, you have a better chance at avoiding an ACL tear.”

Dr. Harrison also emphasized fitting equipment properly, not using old equipment, and wearing a helmet to reduce your risk of injury.

Both Intermountain caregivers are excited for the opportunity to care for some of the world’s top athletes during the 2018 Olympics. With an excellent snowpack and cold winter weather, South Korea’s Winter Games will make for gripping competition.

Intermountain Healthcare is a Utah-based, not-for-profit system of 22 hospitals, a Medical Group with 180 clinics and 1,500 employed physicians and clinicians, a health plans division called SelectHealth, and other health services. Helping people live the healthiest lives possible, Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit IntermountainHealthcare.org.

Daron Cowley
Intermountain Healthcare
801-442-2834
email us here


Source: EIN Presswire

CVR Medical, Canon Showcasing Carotid Stenotic Scan (CSS) at PLASTEC West 2018

PLASTEC West Anaheim 2018

Carotid Stenotic Scan (CSS)

CVR Medical Corp. (OTCQB:CRRVF)

VANCOUVER, BRITISH COLUMBIA, CANADA, February 8, 2018 /EINPresswire.com/ —

CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical” or “CVR”) has joined Canon Virginia, Inc. (CVI) at PLASTEC West (February 6 – 8, 2018), the largest domestic conference and expo for advanced design and manufacturing of plastics technologies. CVI, subsidiary of Canon U.S.A., Inc, is the sole manufacturer of the cart for CVR Medical’s “Carotid Stenotic Scan (CSS)” device.

CVI is sharing a booth with CVR at the event, highlighting abilities that allow for the unique, customized manufacturing of the CSS, as well as logistics and product support needs. The partnership, announced in 2017, established the production pathway through which the CSS will be launched later this year. PLASTEC West draws over 20,000 engineers, executives, and industry luminaries, providing invaluable brand exposure for both companies that are presenting ground-breaking solutions in manufacturing and medicine.

CVR COO Tony Robinson states, “We are excited to attend [PLASTEC West] and show off the results from what has been an incredible partnership. Working with CVI to create the best possible design, and have it manufactured with a streamlined supply chain, has made it possible for us to aim for our highest goals. They have set a new industry quality standard, and we’re proud to reflect that with our device.”

For additional information on the organization, leadership, and current news, please visit the company’s website www.CVRMed.com.

About CVR Medical

CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. (the "Joint Venture"). The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team. CVR Medical trades on the TSX Venture Exchange under the symbol CVM.

ON BEHALF OF THE BOARD:
(signed) "Peter Bakema"
CEO, President & Director

For further information contact:

Peter Bakema, CEO, President and Director
Telephone: (734) 718-5115
Email: info@cvrmed.com
or
Brisco Capital Partners Corp.
Scott Koyich, President
Telephone: (403) 262-9888

This press release contains forward-looking information that involves various risks and uncertainties regarding future events related to the Joint Venture. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements and are not guarantees of future performance of the Company. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. These forward-looking statements reflect management's current views and are based on certain expectations, estimates and assumptions which may prove to be incorrect. A number of risks and uncertainties could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, including: (1) a downturn in general economic conditions in North America and internationally, (2) the inherent uncertainties and speculative nature associated with commercialization of technology and the practice of medicine, (3) a change in health regulations, (4) any number of events or causes which may delay or cease commercialization and development of the Joint Venture, (5) the risk that the Company or the Joint Venture does not execute its business plan, (6) inability to retain key employees, (7) inability to finance operations and growth, and (8) other factors beyond the Company's control. These forward-looking statements are made as of the date of this news release and, except as required by law, the Company assumes no obligation to update these forward-looking statements, or to update the reasons why actual results differed from those projected in the forward-looking statements.

THE TSX VENTURE EXCHANGE INC. HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS PRESS RELEASE. NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Peter Bakema
CVR Medical Corp.
734-718-5115
email us here


Source: EIN Presswire

Trifecta Pharmaceuticals USA brings ancient Chinese medicine principles to treatment of hemorrhoids

Mayinglong ointment is available for purchase at www.mayinglongusa.com

Effective ointment for hemorrhoid treatment is now available in the United States.

FORT LAUDERDALE, FL, USA, February 8, 2018 /EINPresswire.com/ — TRIFECTA PHARMACEUTICALS, a leading developer, manufacturer and distributor of specialty OTC topical ointments, creams and gels, is bringing the principles of ancient Chinese medicine to hemorrhoid sufferers in the United States.

The ointment – known as Mayinglong (Ma-Ying-Long) – is boosted with the addition of seven traditional Chinese compounds, including those derived from rosemary oil, pine resin and powdered pearl, as well as other proteins and minerals providing antioxidant, astringent and moisturizing properties. The ingredients contained in Mayinglong ointment have been used in Asia since 1582.

Trifecta Pharmaceuticals USA Chief Executive, Mr. Greg Brondou, said, “Traditional Chinese medicine principles have been embraced as part of a holistic approach to health care in the US for many years. Trifecta Pharmaceuticals USA is proud to be at the forefront of delivering effective treatments that combine popular compounds used in Traditional Chinese medicine, with our signature easy-to-apply ointment formulation.”

Mayinglong ointment is available for purchase in local independent pharmacies as well as online at www.mayinglongusa.com.

Trifecta Pharmaceuticals’ resident Registered Pharmacist, Mr. Svet Milic, said, “Mayinglong ointment helps provide real relief to people managing hemorrhoids. Beyond reducing pain, discomfort, heat and inflammation, Mayinglong helps to shrink swollen tissue in the area and clear away toxic materials and remove decayed tissue. New tissue growth is stimulated as the inflammation is reduced and hemorrhoids begin to heal.”

-ENDS-

About Trifecta Pharmaceuticals USA
Trifecta Pharmaceuticals is a leading developer, manufacturer and distributor of specialty over-the-counter (OTC) topical ointments, creams, gels and oral rehydration salts. The company prides itself on delivering the highest standards in quality, value and service to its customers across the United States.

In addition to its US commercial operations, Trifecta Pharmaceuticals works closely with international NGOs, charitable organizations and government agencies as the preferred provider of generic pharmaceuticals, medical supplies and topical applications.

Trifecta Pharmaceuticals products are available at pharmacies, Amazon.com and via healthcare distributors nationwide. For more information, please visit www.trifecta-pharma.com.

Media and product information enquiries

SALES AND MARKETING
Trifecta Pharmaceuticals USA
info@trifecta-pharma.com
1 888 296 9067

MEDIA AND PUBLIC RELATIONS
Catherine Corcoran
Trifecta Pharmaceuticals USA
813 895 4575

1 888 296 9067
email us here
Sales and Marketing
Trifecta Pharmaceuticals USA


Source: EIN Presswire

Adaptive Designs in Clinical Trials conference returns to central London in April 2018

The Adaptive Designs in Clinical Trials conference returns to central London in April 2018.

LONDON, UNITED KINGDOM, February 8, 2018 /EINPresswire.com/ — Press Release – 07.02.28

In its 10th year, the Adaptive Designs in Clinical Trials conference returns to central London in April 2018. SMi Group are pleased to invite you to join us on 9th-10th of April at the Copthorne Tara Hotel in Kensington.

The agenda is packed with expert speakers, informative content, senior figures and a keynote address exploring the latest innovations, regulatory updates, and strategies on how industry and clinical experts are currently using adaptive designs in their clinical trials for successful drug, medical device and therapy development. Hear from the likes of Boehringer-Ingelheim, GlaxoSmithKline, Sanofi Aventis, AstraZeneca and more, as we hold candid conversations on drug delivery, nanoparticles/nanomedicine & QbD, CNS drug delivery and therapeutic application.

Day 1
Keynote Address – Innovations in Clinical Trial Design: Lessons Learned from Adaptive Designs presented by Christine Fletcher of Amgen.
Spotlight Sessions – 1. Regulatory Perspective on Adaptive Design Trials – Beatrice Panico, Medical Assessor, MHRA and 2. Sequential Trials in the Context of Competing Risk, presented by Corine Baayen ofH.Lundbeck

Day 2
Opening Address – Platform Studies in Drug Development, James Matcham, AstraZeneca
Spotlight Sessions – 1. Regulatory Perspective for the Planning and Assessment of Umbrella and Basket Trials, Oliver Collignon. Biostatistician, European Medicines Agency and 2. Panel Discussion: Experimental and Novel Approaches in Adaptive Designs with James Matcham of AstraZeneca, Oliver Collignon from the European Medicines Agency and Ros Walley from UCB Pharma.

Workshop – Wednesday 11 April 2018
Two interactive half-day post-conference Workshops exploring Multiple Hypothesis Testing in Group Sequential & Adaptive Clinical Trials with Christopher Jennison from University of Bath and Unlocking the Potential of Platform Trials with Tom Parke of Berry Consulting.

You can view the latest agenda online, as well as secure your place. Please visit, www.adaptivedesigns.co.uk/prpp.

Sponsorship – Please contact: Alia Malick on +44 (0) 7827 6168 or amalick@smi-online.co.uk for more details.

Registration – Register online at: www.adaptivedesigns.co.uk/prpp

—ENDS—

Alan Caddick
Mr.
2087826038
email us here


Source: EIN Presswire

Clinical Alarm Management Market 2018 Global Analysis, Opportunities and Forecast To 2023

Clinical Alarm Management -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022

PUNE, MAHARASHTRA, INDIA, February 8, 2018 /EINPresswire.com/ — Clinical Alarm Management Industry

Description

Wiseguyreports.Com Adds “Clinical Alarm Management -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022” To Its Research Database

According to Stratistics MRC, the Global Clinical Alarm Management Market is accounted for $XX million in 2015 and is expected to reach $XX million by 2022 growing at a CAGR of XX% during the forecast period. Increased investments by governments across the world and growing importance of patient safety are some of the key factors driving the market growth. However, lack of standardization across the nations and improper management in adjusting these systems that leads to false alarms are some of the factors hampering the market.

North America is expected to command the market in terms of both demand and revenue attributed to increased awareness on healthcare advancements in the region. Moreover, emerging countries of Latin America and Asia-Pacific are expected to generate lucrative market opportunities. This is due to increased access to organized healthcare and growing disposable income level donation to private healthcare expenditure in these regions.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/731653-clinical-alarm-management-global-market-outlook-2016-2022

Some of the key players in Clinical Alarm Management market include

GE Healthcare, Medtronic, Mindray Medical International Limited, Baxter, Extension Healthcare and Koninklijke Philips N.V.

Product Types Covered:
• Anesthesia Machines
• Feeding Pumps
• Telemetry monitors
• Infusion Pumps
• Bed Alarms
• Physiological monitors
• Nurse Call System
• Ventilators
• Compression Pumps

End Users Covered:
• Long term and palliative care centers
• Hospitals
• Ambulatory surgical centers
• Home care
• Clinics
• Other End Users

Leave a Query @ https://www.wiseguyreports.com/enquiry/731653-clinical-alarm-management-global-market-outlook-2016-2022

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=731653

Continued…

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire